Raphael F. Smith - Concepedia

Author

Raphael F. Smith

Vanderbilt University

Also Known As

R F Smith, R. F. Smith, R.F. Smith, RAPHAEL F. SMITH, Raphael F Smith, Raphael F. Smith, Raphael Smith

Publications

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Vanderbilt University Medical Center Smith Family Nashville VA Medical Center Naval Aerospace Medical Institute

About

Raphael F. Smith is an author at Vanderbilt University specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	1.3K
2	Health Sciences	5	5	190
3	Public Health	5	5	166
4	Anesthesia	5	5	299
5	Social Sciences	4	4	161

Raphael F. Smith

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure Jay N. Cohn, Gary R. Johnson, Susan Ziesche, New England Journal of Medicine	1991	2.8K
Effect of the Calcium Antagonist Felodipine as Supplementary Vasodilator Therapy in Patients With Chronic Heart Failure Treated With Enalapril Jay N. Cohn, Susan Ziesche, Raphael F. Smith, Circulation	1997	357
Effect of Short-Term Infusion of Sodium Nitroprusside on Mortality Rate in Acute Myocardial Infarction Complicated by Left Ventricular Failure Jay N. Cohn, Joseph A. Franciosa, Gary S. Francis, New England Journal of Medicine	1982	258
Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamide Dan M. Roden, Stots B. Reele, Stanley B. Higgins, The American Journal of Cardiology Heart FailureCardiovascular DiseaseMedicineCardiovascular PharmacologyHuman Subjects	1980	162
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide Henry J. Duff, Dan M. Roden, Rebecca J. Maffucci, The American Journal of Cardiology Cardiac AnaesthesiaCardiovascular DiseasePharmacologyCardiovascular PharmacologyPharmacotherapy	1981	149
Suppression of ventricular ectopic depolarizations by tocainide. Raymond L. Woosley, D. G. McDevitt, Alan S. Nies, Circulation Molecular PharmacologyCardiac MuscleHeart FailureVentricular Ectopic DepolarizationsDosage Increment	1977	96
Antiarrhythmic effects of a lidocaine congener, tocainide, 2‐amino‐2',6'‐propionoxylidide, in man D. G. McDevitt, Alan S. Nies, G. Wilkinson, Clinical Pharmacology & Therapeutics HypertensionHeart FailureCardiovascular PharmacologyAnesthetic MechanismPharmacotherapy	1976	92
Mechanism of death in heart failure : the vasodilator-heart failure trials Steven Goldman, Gary R. Johnson, Jay N. Cohn, Circulation Heart FailureCardiovascular PharmacologyCardiopulmonary TransplantationDiastolic FunctionThrombosis	1993	80
The Wolff-Parkinson-White Syndrome as an Aviation Risk Raphael F. Smith Circulation Neurological DisorderParkinson DiseaseMotor DisorderAviation RiskNeuropathology	1964	77
Electrophysiologic actions of O-demethyl encainide: an active metabolite. Henry J. Duff, Albert K. Dawson, Dan M. Roden, Circulation Molecular PharmacologyElectrophysiologic ActionsBiochemistryNeurophysiologyMedicine	1983	59

Page 1